Navigation Links
Cell Biosciences Announces First UK System Sale
Date:3/10/2009

PALO ALTO, Calif., March 10 /PRNewswire/ -- Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the sale of its flagship protein analysis system to The University of Manchester's Stem Cell and Leukaemia Proteomics Laboratory, led by Professor Tony Whetton. Professor Whetton is a pioneer in the use of advanced proteomics technologies to understand biological processes in normal and leukaemic stem cells. The Cell Biosciences system will be used to study how phosphoprotein signaling processes in hematopoietic stem cells are affected during leukaemia.

"My laboratory has developed a number of new methods to look at changes in protein status within cells," said Professor Whetton. "We believe that the Cell Biosciences system will provide important new insights into the effect of leukaemogenic proteins on stem cell processes."

The Cell Biosciences platform is an ultrasensitive nanofluidic immunoassay system designed to analyze extremely small biological samples. Traditional protein analysis techniques can require as many as 100,000 cells, which complicates protein analysis in stem cells and other precious samples. Because of the Cell Biosciences system's high detection sensitivity, it can measure cell signaling proteins reproducibly in as few as 25 cells.

"The University of Manchester is an ideal location for our first UK placement," said Tim Harkness, President and Chief Executive Officer at Cell Biosciences. "We are pleased to see our products adopted by such a prestigious institution."

Cancer research in Manchester recently was rated best in the UK by the government-led Research Assessment Exercise (RAE), a comprehensive assessment of the quality of research at UK universities. The University of Manchester represents the second Cell Biosciences system sale in Europe.

About Cell Biosciences

Cell Biosciences is a private life sciences company focused on nanoproteomics. We develop instrumentation systems and assays for the measurement of phosphoprotein signaling and activation in extremely small biological samples. Our company's lead product is a capillary-based nanofluidic immunoassay platform that provides quantitative and reproducible data on key signaling pathways in precious biological samples, such as small tumor biopsies and stem cells. Cell Biosciences is located in Palo Alto, California.

www.cellbiosciences.com

info@cellbiosciences.com


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Regado Biosciences to Present at the 2009 Wharton Healthcare Business Conference
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results
3. Enlight Biosciences Expands to direct up to $52 Million to Transformational Enabling Technologies
4. New Jersey-Based Biotech Start-Up Nexomics Biosciences Gets Off the Ground
5. URMC, Lighthouse Biosciences Awarded U.S. Patent for Diagnostic Technology
6. URMC, Lighthouse Biosciences awarded US patent for diagnostic technology
7. Abbott Completes Acquisition of Ibis Biosciences, a Subsidiary of Isis
8. CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform
9. Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus
10. Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance
11. Cell Biosciences Introduces First Protein Analysis Kits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 ... care operating models within the health care industry is ... financial efficiency , Deloitte offers a suite of ... business issues impacting efficient cost optimization: labor resource analysis, ... These services facilitate better outcomes and better economics ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
Breaking Medicine Technology: